ARCHIVES

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

Hammer Blast GAO Report As ”Gobblygook”

June 12, 1987

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

November 27, 1987